Literature DB >> 28139839

A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.

C-C Tzeng1, L-P Tsai2,3, Y-K Chang3,2, Y-J Hung4, Y-Y Chang5, Y-P Su6, J-J Jiang7, H-M Liang8.   

Abstract

Here, we review the results of Southern blotting analyses of the FMR1 gene performed in our reference laboratory in Taiwan over a 15-year period. In total, 725 high-risk women with a family history of fragile X syndrome (FXS) or idiopathic intellectual disability, 3911 low-risk pregnant women without such family history, and prenatal diagnosis data for 32 foetuses from 24 carrier mothers were included. Only 2 carriers were in the low-risk group, which indicated a prevalence of 1 of 1955 women (95% confidence interval: 1/7156-1/539). A total of 100 carriers were found to be in the high-risk group, thus revealing a significantly higher frequency than the low-risk group (100/725 vs 2/3911, P<0.0001). Eight of the 14 foetuses that inherited the maternal mutant allele were verified to have a full mutation, with the smallest maternal pre-mutation allele carrying 56 CGG repeats. The overall findings confirmed that the carrier prevalence among low-risk women in Taiwan is significantly lower than that reported in western countries. Therefore, the most important step for preventing FXS in Taiwan would be to focus on high-risk women by promoting general awareness of this disease and spreading knowledge regarding the benefits of carrier screening and prenatal testing.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990FMR1zzm321990; Southern blotting; carrier screening; fragile X syndrome; idiopathic intellectual disability; prenatal testing

Mesh:

Substances:

Year:  2017        PMID: 28139839     DOI: 10.1111/cge.12981

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  The prevalence of CGG repeat expansion mutation in FMR1 gene in the northern Chinese women of reproductive age.

Authors:  Yinan Ma; Xing Wei; Hong Pan; Songtao Wang; Xin Wang; Xiaowei Liu; Liying Zou; Xiaomei Wang; Xiaorong Wang; Hua Yang; Fengying Wang; Kefang Wang; Lifang Sun; Xiaolin Qiao; Yue Yang; Xiuhua Ma; Dandan Liu; Guifeng Ding; Junqi Ma; Xiuli Yang; Sainan Zhu; Yu Qi; Chenghong Yin
Journal:  BMC Med Genet       Date:  2019-05-16       Impact factor: 2.103

2.  A capillary electrophoresis-based multiplex PCR assay for expanded carrier screening in the eastern Han Chinese population.

Authors:  Ping Hu; Jianxin Tan; Feng Yu; Binbin Shao; Fang Zhang; Jingjing Zhang; Yingchun Lin; Tao Tao; Lili Jiang; Zhengwen Jiang; Zhengfeng Xu
Journal:  NPJ Genom Med       Date:  2022-01-25       Impact factor: 8.617

3.  Development of Chinese genetic reference panel for Fragile X Syndrome and its application to the screen of 10,000 Chinese pregnant women and women planning pregnancy.

Authors:  Fei Gao; Wen Huang; Yanjun You; Jie Huang; Juan Zhao; Jin Xue; Huaixing Kang; Yingbao Zhu; Zhengmao Hu; Emily G Allen; Peng Jin; Kun Xia; Ranhui Duan
Journal:  Mol Genet Genomic Med       Date:  2020-04-12       Impact factor: 2.183

4.  The significance of FMR1 CGG repeats in Chinese women with premature ovarian insufficiency and diminished ovarian reserve.

Authors:  Ruiyi Tang; Qi Yu
Journal:  Reprod Biol Endocrinol       Date:  2020-08-12       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.